{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:40:37Z","timestamp":1792478437461,"version":"4.5.0"},"reference-count":340,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","award":["YX202212"],"award-info":[{"award-number":["YX202212"]}],"id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.biopha.2025.118367","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T21:46:35Z","timestamp":1753479995000},"page":"118367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Histone deacetylases in myocardial infarction: Orchestrating programmed cell death pathways and emerging therapeutic opportunities"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6342-608X","authenticated-orcid":false,"given":"Huai","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marady","family":"Hun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingna","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingnan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2025.118367_bib1","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 Heart disease and stroke statistics: a report of US and global data from the american heart association","volume":"151","author":"Martin","year":"2025","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.biopha.2025.118367_bib2","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the american heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"10440","key":"10.1016\/j.biopha.2025.118367_bib3","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Diseases","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118367_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","author":"Rao","year":"2025","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.biopha.2025.118367_bib5","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2025.118367_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s10495-025-02075-3","article-title":"Programmed cardiomyocyte death in myocardial infarction","author":"Wu","year":"2025","journal-title":"Apopt. Int. J. Program. Cell death"},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCRESAHA.121.319584","article-title":"Multiple cell death programs contribute to myocardial infarction","volume":"129","author":"Jia","year":"2021","journal-title":"Circ. Res."},{"issue":"27","key":"10.1016\/j.biopha.2025.118367_bib8","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1093\/eurheartj\/ehac223","article-title":"Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies","volume":"43","author":"Frantz","year":"2022","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.biopha.2025.118367_bib10","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1606915","article-title":"Acute myocardial infarction","volume":"376","author":"Anderson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2025.118367_bib11","article-title":"The role of cardiac pericytes in health and disease: therapeutic targets for myocardial infarction","author":"Avolio","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/cvr\/cvs109","article-title":"Novel therapeutic approaches to post-infarction remodelling","volume":"94","author":"Fraccarollo","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2025.118367_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40824-016-0060-8","article-title":"Antifibrotic therapies to control cardiac fibrosis","volume":"20","author":"Fan","year":"2016","journal-title":"Biomater. Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol. Life Sci."},{"issue":"15","key":"10.1016\/j.biopha.2025.118367_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22157831","article-title":"Targeting inflammation after myocardial infarction: a therapeutic opportunity for extracellular vesicles?","volume":"22","author":"Viola","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCRESAHA.114.300639","article-title":"Exosomes and cardiac repair after myocardial infarction","volume":"114","author":"Sahoo","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118367_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102629","article-title":"Regulated cell death in acute myocardial infarction: molecular mechanisms and therapeutic implications","volume":"104","author":"Zhu","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib19","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.tips.2007.07.004","article-title":"Programmed death as a therapeutic target to reduce myocardial infarction","volume":"28","author":"Webster","year":"2007","journal-title":"Trends Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","article-title":"Cell death","volume":"187","author":"Newton","year":"2024","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","article-title":"Emerging connectivity of programmed cell death pathways and its physiological implications","volume":"21","author":"Bedoui","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/imr.13303","article-title":"Mechanisms of programmed cell death","volume":"321","author":"Li","year":"2024","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118367_bib24","article-title":"Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets","volume":"5","author":"Qian","year":"2024","journal-title":"MedComm (2020)"},{"issue":"9239","key":"10.1016\/j.biopha.2025.118367_bib25","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(05)74077-0","article-title":"Cell death in myocardial infarction","volume":"356","author":"De Sutter","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118367_bib26","article-title":"Comprehensive bioinformatics analysis reveals the role of cuproptosis-related gene Ube2d3 in myocardial infarction","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118367_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1213995","article-title":"Mechanisms of alkaliptosis","volume":"11","author":"Chen","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118367_bib28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.tips.2024.06.002","article-title":"PANoptosis: a novel target for cardiovascular diseases","volume":"45","author":"Xiang","year":"2024","journal-title":"Trends Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-022-01055-2","article-title":"Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials","volume":"7","author":"Shi","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2025.118367_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yjmcc.2019.01.019","article-title":"Epigenetics, cardiovascular disease, and cellular reprogramming","volume":"128","author":"Al-Hasani","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib31","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrcardio.2010.104","article-title":"Epigenetics and cardiovascular disease","volume":"7","author":"Ordovas","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118367_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155532","article-title":"The role of histone deacetylases in cardiac energy metabolism in heart diseases","volume":"142","author":"Yu","year":"2023","journal-title":"Metab. Clin. Exp."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib33","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.apsb.2023.02.007","article-title":"Targeting histone deacetylases for cancer therapy: trends and challenges","volume":"13","author":"Liang","year":"2023","journal-title":"Acta Pharm. Sin. B."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib34","doi-asserted-by":"crossref","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"Pt 2","key":"10.1016\/j.biopha.2025.118367_bib35","article-title":"Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment","volume":"245","author":"Yang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib36","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.drudis.2015.01.007","article-title":"Histone deacetylases: structural determinants of inhibitor selectivity","volume":"20","author":"Micelli","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2025.118367_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2014.11.003","article-title":"Histone deacetylases as therapeutic targets--from cancer to cardiac disease","volume":"147","author":"Abend","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"24","key":"10.1016\/j.biopha.2025.118367_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13247797","article-title":"Histone deacetylase inhibitors as a promising treatment against myocardial infarction: a systematic review","volume":"13","author":"Sanchez-Fernandez","year":"2024","journal-title":"J. Clin. Med"},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib39","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016349","article-title":"Histone deacetylase inhibitors: a novel strategy for neuroprotection and cardioprotection following ischemia\/reperfusion injury","volume":"9","author":"Pickell","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2025.118367_bib40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.yjmcc.2019.02.013","article-title":"HDAC inhibition as a therapeutic strategy in myocardial ischemia\/reperfusion injury","volume":"129","author":"Xie","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"19","key":"10.1016\/j.biopha.2025.118367_bib41","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1161\/CIRCULATIONAHA.121.054262","article-title":"HDAC inhibition in the heart: erasing hidden fibrosis","volume":"143","author":"Gillette","year":"2021","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib42","first-page":"471","article-title":"Critical functions of histone deacetylases (HDACs) in modulating inflammation associated with cardiovascular diseases","volume":"29","author":"Kulthinee","year":"2022","journal-title":"Pathophysiol. Off. J. Int. Soc. Pathophysiol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib43","first-page":"132","article-title":"HDACs as a therapeutic target in HFpEF","volume":"17","author":"Fern\u00e1ndez-Ruiz","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118367_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2016.03.188","article-title":"HDAC inhibition: a novel therapeutic approach for attenuating heart failure by suppressing cardiac remodeling","volume":"214","author":"Wang","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.118367_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103321","article-title":"Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis","volume":"76","author":"Chen","year":"2024","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCRESAHA.123.322596","article-title":"TGF-\u03b21\/SMAD3 regulates programmed cell death 5 that suppresses cardiac fibrosis post-myocardial infarction by inhibiting HDAC3","volume":"133","author":"Weng","year":"2023","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib47","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2174\/1389450123666221003094908","article-title":"Therapeutic potential of HDAC inhibitors in the treatment of cardiac diseases: a short review","volume":"24","author":"Tiwari","year":"2023","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biopha.2025.118367_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.863677","article-title":"New insight in HDACs: potential therapeutic targets for the treatment of atherosclerosis","volume":"13","author":"Luan","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib49","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.tplants.2023.06.006","article-title":"Multifaceted functions of histone deacetylases in stress response","volume":"28","author":"Cui","year":"2023","journal-title":"Trends Plant Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/13543776.2023.2219393","article-title":"An updated patent review of histone deacetylase (HDAC) inhibitors in cancer (2020 - present)","volume":"33","author":"Liu","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib51","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1471-4892(03)00084-5","article-title":"Histone deacetylases","volume":"3","author":"Marks","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1868-7083-4-5","article-title":"Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors","volume":"4","author":"Delcuve","year":"2012","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.biopha.2025.118367_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116696","article-title":"Overview of class I HDAC modulators: inhibitors and degraders","volume":"276","author":"Huang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"Pt 3","key":"10.1016\/j.biopha.2025.118367_bib54","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","article-title":"Histone deacetylases (HDACs): characterization of the classical HDAC family","volume":"370","author":"de Ruijter","year":"2003","journal-title":"Biochem J."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tips.2016.12.006","article-title":"Targeting class I histone deacetylases in a \"Complex\" environment","volume":"38","author":"Millard","year":"2017","journal-title":"Trends Pharm. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib56","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0168-9525(03)00073-8","article-title":"Class II histone deacetylases: versatile regulators","volume":"19","author":"Verdin","year":"2003","journal-title":"Trends Genet"},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib57","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1139\/o01-116","article-title":"The emerging role of class II histone deacetylases","volume":"79","author":"Fischle","year":"2001","journal-title":"Biochem Cell Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1139\/o01-032","article-title":"Class II histone deacetylases: structure, function, and regulation","volume":"79","author":"Bertos","year":"2001","journal-title":"Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118367_bib59","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41419-023-06319-5","article-title":"Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity","volume":"14","author":"Martin","year":"2023","journal-title":"Cell death Dis."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib60","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/febs.13061","article-title":"Class IIa HDACs - new insights into their functions in physiology and pathology","volume":"282","author":"Parra","year":"2015","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.biopha.2025.118367_bib61","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1021\/acs.accounts.3c00801","article-title":"Chemical versatility in catalysis and inhibition of the class IIb histone deacetylases","volume":"57","author":"Christianson","year":"2024","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib62","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41580-018-0076-0","article-title":"Integrative regulation of physiology by histone deacetylase 3","volume":"20","author":"Emmett","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118367_bib63","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.biochem.74.082803.133500","article-title":"The biochemistry of sirtuins","volume":"75","author":"Sauve","year":"2006","journal-title":"Annu Rev. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/biof.1032","article-title":"Sirtuin activators and inhibitors","volume":"38","author":"Villalba","year":"2012","journal-title":"Biofactors"},{"key":"10.1016\/j.biopha.2025.118367_bib65","article-title":"HDAC11: a rising star in epigenetics","volume":"131","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118367_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ebiom.2018.08.008","article-title":"Histone deacetylase 11 as a key regulator of metabolism and obesity","volume":"35","author":"Bhaskara","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2025.118367_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116312","article-title":"Unraveling HDAC11: epigenetic orchestra in different diseases and structural insights for inhibitor design","volume":"225","author":"Khatun","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"13","key":"10.1016\/j.biopha.2025.118367_bib68","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00018-012-0921-9","article-title":"Multiple roles of class I HDACs in proliferation, differentiation, and development","volume":"69","author":"Reichert","year":"2012","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib69","doi-asserted-by":"crossref","first-page":"773","DOI":"10.14336\/AD.2021.1116","article-title":"Histone deacetylase 3: a potential therapeutic target for atherosclerosis","volume":"13","author":"Jiang","year":"2022","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib70","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molcel.2008.02.030","article-title":"Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control","volume":"30","author":"Bhaskara","year":"2008","journal-title":"Mol. Cell"},{"issue":"422","key":"10.1016\/j.biopha.2025.118367_bib71","doi-asserted-by":"crossref","first-page":"ra34","DOI":"10.1126\/scisignal.aad5736","article-title":"Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression","volume":"9","author":"Morales","year":"2016","journal-title":"Sci. Signal"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib72","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1097-2765(01)00429-4","article-title":"Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT\/N-CoR","volume":"9","author":"Fischle","year":"2002","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1101\/gad.14.1.55","article-title":"Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression","volume":"14","author":"Kao","year":"2000","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib74","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1152\/japplphysiol.00006.2018","article-title":"Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium","volume":"125","author":"Zhang","year":"2018","journal-title":"J. Appl. Physiol. (Bethesda Md. 1985)."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib75","doi-asserted-by":"crossref","first-page":"C358","DOI":"10.1152\/ajpcell.00187.2013","article-title":"Specific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs","volume":"307","author":"Zhang","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib76","doi-asserted-by":"crossref","first-page":"H1894","DOI":"10.1152\/ajpheart.01039.2011","article-title":"HDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats","volume":"302","author":"Usui","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"47","key":"10.1016\/j.biopha.2025.118367_bib77","doi-asserted-by":"crossref","first-page":"39338","DOI":"10.1074\/jbc.M112.379115","article-title":"Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts","volume":"287","author":"Zhang","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118367_bib78","article-title":"HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model","volume":"134","author":"Bai","year":"2021","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib79","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1172\/JCI133753","article-title":"Salt-inducible kinase 1 maintains HDAC7 stability to promote pathologic cardiac remodeling","volume":"130","author":"Hsu","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib80","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/ATVBAHA.114.303393","article-title":"N. Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development","volume":"34","author":"Cao","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib81","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/CIRCRESAHA.120.317723","article-title":"HDAC9: an inflammatory link in atherosclerosis","volume":"127","author":"Das","year":"2020","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib82","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1073\/pnas.96.9.4868","article-title":"Three proteins define a class of human histone deacetylases related to yeast Hda1p","volume":"96","author":"Grozinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165903","article-title":"HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1beta secretion in diabetic mice","volume":"1866","author":"Karnam","year":"2020","journal-title":"Biochim. Et. Biophys. Acta Mol. basis Dis."},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib84","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.7150\/thno.82535","article-title":"The HDAC10 instructs macrophage M2 program via deacetylation of STAT3 and promotes allergic airway inflammation","volume":"13","author":"Zhong","year":"2023","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib85","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/nar\/30.5.1114","article-title":"Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain","volume":"30","author":"Tong","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib86","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2006.07.002","article-title":"Sirtuins in aging and age-related disease","volume":"126","author":"Longo","year":"2006","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib87","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/138161209787185742","article-title":"NAD(+), sirtuins, and cardiovascular disease","volume":"15","author":"Borradaile","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2025.118367_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106957","article-title":"SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion","volume":"199","author":"Ding","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib89","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7150\/ijbs.78654","article-title":"Novel role of the SIRT1 in endocrine and metabolic diseases","volume":"19","author":"Lu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.118367_bib90","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cca.2014.07.019","article-title":"SIRT1 in cardiovascular aging","volume":"437","author":"Luo","year":"2014","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"45","key":"10.1016\/j.biopha.2025.118367_bib91","doi-asserted-by":"crossref","first-page":"15998","DOI":"10.1073\/pnas.0404184101","article-title":"Sir2 mediates longevity in the fly through a pathway related to calorie restriction","volume":"101","author":"Rogina","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6825","key":"10.1016\/j.biopha.2025.118367_bib92","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/35065638","article-title":"Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans","volume":"410","author":"Tissenbaum","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118367_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176155","article-title":"A review on SIRT3 and its natural small molecule activators as a potential Preventive and therapeutic target","volume":"963","author":"Liu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib94","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1002\/jcp.27329","article-title":"The novel relationship between Sirt3 and autophagy in myocardial ischemia-reperfusion","volume":"234","author":"Zheng","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118367_bib95","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.bbadis.2016.10.021","article-title":"Sirt3 deficiency exacerbates diabetic cardiac dysfunction: role of Foxo3A-Parkin-mediated mitophagy","volume":"1863","author":"Yu","year":"2017","journal-title":"Biochim. Et. Biophys. Acta Mol. basis Dis."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib96","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1159\/000354469","article-title":"SIRT4 prevents hypoxia-induced apoptosis in H9c2 cardiomyoblast cells","volume":"32","author":"Liu","year":"2013","journal-title":"Cell Physiol. Biochem"},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib97","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1159\/000354505","article-title":"SIRT5: a safeguard against oxidative stress-induced apoptosis in cardiomyocytes","volume":"32","author":"Liu","year":"2013","journal-title":"Cell Physiol. Biochem"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib98","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yexcr.2014.07.013","article-title":"Sirtuin 6 protects the heart from hypoxic damage","volume":"330","author":"Maksin-Matveev","year":"2015","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib99","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00044.2022","article-title":"SIRT7: the seventh key to unlocking the mystery of aging","volume":"104","author":"Raza","year":"2024","journal-title":"Physiol. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2025.118367_bib100","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","article-title":"Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases","volume":"123","author":"Kane","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118367_bib101","article-title":"HDAC11: a novel target for improved cancer therapy","volume":"166","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118367_bib102","article-title":"HDAC11, an emerging therapeutic target for metabolic disorders","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib103","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ni.1673","article-title":"The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance","volume":"10","author":"Villagra","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2025.118367_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.656272","article-title":"Hydroxytyrosol acetate inhibits vascular endothelial cell pyroptosis via the HDAC11 signaling pathway in atherosclerosis","volume":"12","author":"Yao","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41420-022-00906-9","article-title":"HDAC11 promotes both NLRP3\/caspase-1\/GSDMD and caspase-3\/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells","volume":"8","author":"Yao","year":"2022","journal-title":"Cell Death Discov."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib106","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell death Differ."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib107","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib108","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br. J. Cancer"},{"issue":"6805","key":"10.1016\/j.biopha.2025.118367_bib109","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib110","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0962-8924(01)02124-9","article-title":"Apoptosis and cancer chemotherapy","volume":"11","author":"Makin","year":"2001","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.biopha.2025.118367_bib111","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-immunol-042617-053010","article-title":"Apoptosis and clearance of apoptotic cells","volume":"36","author":"Nagata","year":"2018","journal-title":"Annu Rev. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib112","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/cr.2007.52","article-title":"Apoptosis signaling pathways and lymphocyte homeostasis","volume":"17","author":"Xu","year":"2007","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2025.118367_bib113","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.biochem.69.1.217","article-title":"Apoptosis signaling","volume":"69","author":"Strasser","year":"2000","journal-title":"Annu Rev. Biochem"},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib114","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.copbio.2010.07.001","article-title":"Systems biology of apoptosis signaling networks","volume":"21","author":"Lavrik","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118367_bib115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pathol-052016-100247","article-title":"Necroptosis: mechanisms and relevance to disease","volume":"12","author":"Galluzzi","year":"2017","journal-title":"Annu Rev. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib116","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1310050","article-title":"Necroptosis","volume":"370","author":"Linkermann","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib117","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib118","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib119","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12974-018-1235-0","article-title":"Necroptosis: a regulated inflammatory mode of cell death","volume":"15","author":"Dhuriya","year":"2018","journal-title":"J. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib121","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s12276-021-00634-7","article-title":"Necroptosis molecular mechanisms: recent findings regarding novel necroptosis regulators","volume":"53","author":"Seo","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"16","key":"10.1016\/j.biopha.2025.118367_bib122","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMra2022774","article-title":"Autophagy in human diseases","volume":"383","author":"Mizushima","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.biopha.2025.118367_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2019.06.014","article-title":"Autophagy","volume":"29","author":"Wollert","year":"2019","journal-title":"Curr. Biol. CB"},{"key":"10.1016\/j.biopha.2025.118367_bib124","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-biophys-060414-034248","article-title":"Mechanisms of autophagy","volume":"44","author":"Noda","year":"2015","journal-title":"Annu Rev. Biophys."},{"issue":"22","key":"10.1016\/j.biopha.2025.118367_bib125","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: process and function","volume":"21","author":"Mizushima","year":"2007","journal-title":"Genes Dev."},{"issue":"7","key":"10.1016\/j.biopha.2025.118367_bib126","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41583-022-00588-3","article-title":"Macroautophagy in CNS health and disease","volume":"23","author":"Griffey","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib127","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41580-022-00529-z","article-title":"The emerging mechanisms and functions of microautophagy","volume":"24","author":"Wang","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib128","article-title":"Chaperone-mediated autophagy: molecular mechanisms, biological functions, and diseases","volume":"4","author":"Yao","year":"2023","journal-title":"MedComm (2020)"},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib129","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib130","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib131","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib132","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib133","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib134","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib135","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol"},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib136","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cell.2009.08.021","article-title":"Caspases and kinases in a death grip","volume":"138","author":"Kurokawa","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118367_bib137","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.2147\/JIR.S417801","article-title":"Programmed cell death in asthma: apoptosis, autophagy, pyroptosis, ferroptosis, and necroptosis","volume":"16","author":"Liu","year":"2023","journal-title":"J. Inflamm. Res"},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib138","article-title":"Role of pyroptosis in the pathogenesis and treatment of diseases","volume":"4","author":"Jin","year":"2023","journal-title":"MedComm (2020)"},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib139","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.apsb.2021.02.006","article-title":"Gasdermin D in pyroptosis","volume":"11","author":"Burdette","year":"2021","journal-title":"Acta Pharm. Sin. B."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41418-018-0212-6","article-title":"Pyroptosis versus necroptosis: similarities, differences, and crosstalk","volume":"26","author":"Frank","year":"2019","journal-title":"Cell death Differ."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib141","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/078538902321012414","article-title":"Apoptosis in myocardial infarction","volume":"34","author":"Rodr\u00edguez","year":"2002","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib142","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s003950050195","article-title":"Apoptosis and myocardial infarction","volume":"93","author":"Anversa","year":"1998","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.07.005","article-title":"Role of apoptosis in remodeling after myocardial infarction","volume":"104","author":"Takemura","year":"2004","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib144","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12967-017-1191-y","article-title":"Apoptosis in ischemic heart disease","volume":"15","author":"Teringova","year":"2017","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib145","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0735-1097(02)02959-5","article-title":"Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure","volume":"41","author":"Abbate","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib146","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/jmcc.2001.1498","article-title":"Apoptosis and post-infarction left ventricular remodeling","volume":"34","author":"Baldi","year":"2002","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib147","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/j.2040-4603.2015.tb00664.x","article-title":"Pathophysiology of myocardial infarction","volume":"5","author":"Frangogiannis","year":"2015","journal-title":"Compr. Physiol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib148","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.biocel.2006.04.010","article-title":"Acute myocardial infarction and heart failure: role of apoptosis","volume":"38","author":"Abbate","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118367_bib149","article-title":"Astragaloside IV ameliorates myocardial infarction induced apoptosis and restores cardiac function","volume":"9","author":"Sun","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118367_bib150","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1002\/jcp.25857","article-title":"Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury","volume":"232","author":"Wang","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib151","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0008-6363(99)00349-1","article-title":"Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction","volume":"45","author":"Yaoita","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib152","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mco2.108","article-title":"The role of necroptosis in disease and treatment","volume":"2","author":"Liu","year":"2021","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.biopha.2025.118367_bib153","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fphar.2018.00721","article-title":"The role of necroptosis in cardiovascular disease","volume":"9","author":"Zhe-Wei","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib154","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/ajt.12448","article-title":"Necroptosis in immunity and ischemia-reperfusion injury","volume":"13","author":"Linkermann","year":"2013","journal-title":"Am. J. Transpl."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12929-021-00722-w","article-title":"Targeting necroptosis as therapeutic potential in chronic myocardial infarction","volume":"28","author":"Piamsiri","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2025.118367_bib156","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yjmcc.2022.05.006","article-title":"Necroptosis in heart disease: molecular mechanisms and therapeutic implications","volume":"169","author":"Guo","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2025.118367_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173053","article-title":"Arctiin protects rat heart against ischemia\/reperfusion injury via a mechanism involving reduction of necroptosis","volume":"875","author":"Chen","year":"2020","journal-title":"Eur. J. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib158","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.4017","article-title":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis","volume":"22","author":"Zhang","year":"2016","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib159","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/eci.12568","article-title":"Protective role of necrostatin-1 in acute myocardial infarction","volume":"46","author":"Carbone","year":"2016","journal-title":"Eur. J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib160","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/eci.12391","article-title":"Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs","volume":"45","author":"Koudstaal","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib161","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1111\/jcmm.14536","article-title":"Different signalling in infarcted and non-infarcted areas of rat failing hearts: a role of necroptosis and inflammation","volume":"23","author":"Lichy","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib162","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41419-023-05691-6","article-title":"The double-edged functions of necroptosis","volume":"14","author":"Ye","year":"2023","journal-title":"Cell death Dis."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib163","article-title":"The role of RIPK3-regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia-reperfusion injury","volume":"231","author":"Ying","year":"2021","journal-title":"Acta Physiol. (Oxf. Engl. )"},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib164","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/cvr\/cvab158","article-title":"The role of autophagy in cardiovascular pathology","volume":"118","author":"Gatica","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2025.118367_bib165","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3389\/fphar.2019.00551","article-title":"The role of autophagy in acute myocardial infarction","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib166","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.biotechadv.2018.03.012","article-title":"Natural products with anti-aging potential: affected targets and molecular mechanisms","volume":"36","author":"Catana","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biopha.2025.118367_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2024.107691","article-title":"Autophagy in myocardial ischemia and ischemia\/reperfusion","volume":"74","author":"Aljakna Khan","year":"2025","journal-title":"Cardiovasc Pathol."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118367_bib168","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10495-022-01786-1","article-title":"Regulation of autophagy of the heart in ischemia and reperfusion","volume":"28","author":"Popov","year":"2023","journal-title":"Apopt. Int. J. Program. Cell Death"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0000000000001646","article-title":"Role of autophagy in myocardial remodeling after myocardial infarction","volume":"85","author":"Tian","year":"2025","journal-title":"J. Cardiovasc Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib170","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41420-024-02263-1","article-title":"Deptor protects against myocardial ischemia-reperfusion injury by regulating the mTOR signaling and autophagy","volume":"10","author":"Duan","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib171","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/med.21733","article-title":"Autophagy and cardiac diseases: therapeutic potential of natural products","volume":"41","author":"Wu","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib172","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4161\/auto.6.2.11135","article-title":"Augmentation of autophagy by mTOR-inhibition in myocardial infarction: when size matters","volume":"6","author":"Buss","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2025.118367_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174260","article-title":"Sphingosine-1-phosphate induces myocyte autophagy after myocardial infarction through mTOR inhibition","volume":"907","author":"Yang","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib174","doi-asserted-by":"crossref","first-page":"16768","DOI":"10.1002\/jcp.28345","article-title":"Targeting autophagy in cardiac ischemia\/reperfusion injury: a novel therapeutic strategy","volume":"234","author":"Aghaei","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib175","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4161\/auto.4913","article-title":"Myocyte autophagy in heart disease: friend or foe?","volume":"3","author":"Rothermel","year":"2007","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib176","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12012-024-09942-6","article-title":"Persistent ferroptosis modulates cardiac remodeling and M2 macrophage polarization, which can be mitigated by astaxanthin during myocardial infarction recovery","volume":"25","author":"Shen","year":"2025","journal-title":"Cardiovasc Toxicol."},{"key":"10.1016\/j.biopha.2025.118367_bib177","article-title":"EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p\/ACSL4 axis","volume":"119","author":"Yu","year":"2023","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"issue":"1-2","key":"10.1016\/j.biopha.2025.118367_bib178","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10495-022-01785-2","article-title":"Targeting ferroptosis: a novel insight against myocardial infarction and ischemia-reperfusion injuries","volume":"28","author":"Han","year":"2023","journal-title":"Apopt. Int. J. Program. Cell Death"},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib179","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41419-019-2061-8","article-title":"Quantitative proteomic analyses reveal that GPX4 downregulation during myocardial infarction contributes to ferroptosis in cardiomyocytes","volume":"10","author":"Park","year":"2019","journal-title":"Cell death Dis."},{"key":"10.1016\/j.biopha.2025.118367_bib180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.actbio.2021.11.041","article-title":"Amelioration of acute myocardial infarction injury through targeted ferritin nanocages loaded with an ALKBH5 inhibitor","volume":"140","author":"Cheng","year":"2022","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib181","doi-asserted-by":"crossref","first-page":"H659","DOI":"10.1152\/ajpheart.00452.2017","article-title":"Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes","volume":"314","author":"Baba","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib182","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbrc.2018.02.061","article-title":"Puerarin protects against heart failure induced by pressure overload through mitigation of ferroptosis","volume":"497","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib183","first-page":"84","article-title":"How erastin assassinates cells by ferroptosis revealed","volume":"14","author":"Gan","year":"2023","journal-title":"Protein Cell"},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib184","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib185","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/jpp\/rgad080","article-title":"Ferrostatin-1 suppresses cardiomyocyte ferroptosis after myocardial infarction by activating Nrf2 signaling","volume":"75","author":"Wu","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118367_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109257","article-title":"Protective effects of Salvianolic acid B on rat ferroptosis in myocardial infarction through upregulating the Nrf2 signaling pathway","volume":"112","author":"Shen","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib187","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091399","article-title":"The role of ferroptosis in adverse left ventricular remodeling following acute myocardial infarction","volume":"11","author":"Komai","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118367_bib188","article-title":"Ferroptosis: opportunities and challenges in myocardial ischemia-reperfusion injury","volume":"2021","author":"Zhao","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib189","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200367","article-title":"Ferroptosis in myocardial infarction: not a marker but a maker","volume":"11","author":"Wang","year":"2021","journal-title":"Open Biol."},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib190","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111625","article-title":"Pyroptosis: a newly discovered therapeutic target for ischemia-reperfusion injury","volume":"12","author":"Zheng","year":"2022","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib191","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41419-021-04143-3","article-title":"Pyroptosis inhibition improves the symptom of acute myocardial infarction","volume":"12","author":"Liu","year":"2021","journal-title":"Cell death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib192","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.apsb.2022.08.007","article-title":"Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: cumulative evidence for future cardioprotective strategies","volume":"13","author":"Yanpiset","year":"2023","journal-title":"Acta Pharm. Sin. B."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib193","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12967-023-03873-6","article-title":"GSDMD-mediated pyroptosis dominantly promotes left ventricular remodeling and dysfunction in post-myocardial infarction: a comparison across modes of programmed cell death and mitochondrial involvement","volume":"21","author":"Piamsiri","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118367_bib194","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893914","article-title":"GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis","volume":"13","author":"Ye","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118367_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110222","article-title":"Panaxynol ameliorates cardiac ischemia\/reperfusion injury by suppressing NLRP3-induced pyroptosis and apoptosis via HMGB1\/TLR4\/NF-\u03baB axis","volume":"121","author":"Ding","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2025.118367_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110481","article-title":"3,4-benzo[a]pyrene aggravates myocardial infarction injury by activating NLRP3-related pyroptosis through PINK1\/Parkin-mitophagy-mPTP opening axis","volume":"122","author":"Wu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib197","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41419-020-03120-6","article-title":"GDF11 inhibits cardiomyocyte pyroptosis and exerts cardioprotection in acute myocardial infarction mice by upregulation of transcription factor HOXA3","volume":"11","author":"Li","year":"2020","journal-title":"Cell death Dis."},{"key":"10.1016\/j.biopha.2025.118367_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.04.022","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction","volume":"74","author":"Gao","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2025.118367_bib199","article-title":"Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118367_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114677","article-title":"A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells","volume":"194","author":"Lu","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2025.118367_bib201","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s12272-020-01297-0","article-title":"Therapeutic effects of histone deacetylase inhibitors on heart disease","volume":"43","author":"Chun","year":"2020","journal-title":"Arch. pharm. Res."},{"key":"10.1016\/j.biopha.2025.118367_bib202","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yjmcc.2019.07.009","article-title":"Roles and mechanisms of SUMOylation on key proteins in myocardial ischemia\/reperfusion injury","volume":"134","author":"Chen","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2025.118367_bib203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12933-015-0262-8","article-title":"Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice","volume":"14","author":"Chen","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib204","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.7150\/thno.70821","article-title":"Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition","volume":"12","author":"Huang","year":"2022","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib205","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.7150\/thno.70821","article-title":"Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition","volume":"12","author":"Huang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118367_bib206","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2018.12.003","article-title":"HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction","volume":"39","author":"Tian","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2025.118367_bib207","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2018.12.003","article-title":"HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction","volume":"39","author":"Tian","year":"2019","journal-title":"EBioMedicine"},{"issue":"20","key":"10.1016\/j.biopha.2025.118367_bib208","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.7150\/thno.44281","article-title":"Mydgf promotes cardiomyocyte proliferation and neonatal heart regeneration","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib209","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41420-021-00601-1","article-title":"Histone deacetylase HDAC4 participates in the pathological process of myocardial ischemia-reperfusion injury via MEKK1\/JNK pathway by binding to miR-206","volume":"7","author":"Li","year":"2021","journal-title":"Cell death Discov."},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166182","article-title":"Irisin ameliorates hypoxia\/reoxygenation-induced injury through modulation of histone deacetylase 4","volume":"11","author":"Zhao","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2025.118367_bib211","article-title":"Cellular and molecular biology of sirtuins in cardiovascular disease","volume":"164","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118367_bib212","first-page":"690","article-title":"Innovative therapeutic strategies for cardiovascular disease","volume":"22","author":"Maiese","year":"2023","journal-title":"EXCLI J."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib213","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/jcmm.16329","article-title":"Mangiferin prevents myocardial infarction-induced apoptosis and heart failure in mice by activating the Sirt1\/FoxO3a pathway","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"17","key":"10.1016\/j.biopha.2025.118367_bib214","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1093\/cvr\/cvac026","article-title":"SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX","volume":"118","author":"Kuno","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib215","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s10020-025-01155-z","article-title":"Sirtuin1 mitigates hypoxia-induced cardiomyocyte apoptosis in myocardial infarction via PHD3\/HIF-1\u03b1","volume":"31","author":"Chen","year":"2025","journal-title":"Mol. Med. (Camb. Mass. )."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib216","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41420-025-02372-5","article-title":"Different types of cell death and their interactions in myocardial ischemia-reperfusion injury","volume":"11","author":"Du","year":"2025","journal-title":"Cell death Discov."},{"issue":"12","key":"10.1016\/j.biopha.2025.118367_bib217","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1111\/jcmm.16558","article-title":"Exosomes derived from MSC pre-treated with oridonin alleviates myocardial IR injury by suppressing apoptosis via regulating autophagy activation","volume":"25","author":"Fu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib218","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbrc.2018.04.090","article-title":"HDAC11 deletion reduces fructose-induced cardiac dyslipidemia, apoptosis and inflammation by attenuating oxidative stress injury","volume":"503","author":"Fan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2025.118367_bib219","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yjmcc.2019.04.003","article-title":"Histone deacetylases in cardiovascular and metabolic diseases","volume":"130","author":"Bagchi","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib220","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1152\/japplphysiol.00006.2018","article-title":"Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium","volume":"125","author":"Zhang","year":"2018","journal-title":"J. Appl. Physiol. (Bethesda Md. 1985)."},{"issue":"9-10","key":"10.1016\/j.biopha.2025.118367_bib221","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10495-022-01760-x","article-title":"The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic\/reperfusion of cardiac injury","volume":"27","author":"Maslov","year":"2022","journal-title":"Apopt. Int. J. Program. Cell Death"},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib222","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1111\/jcmm.14536","article-title":"Different signalling in infarcted and non-infarcted areas of rat failing hearts: a role of necroptosis and inflammation","volume":"23","author":"Lich\u00fd","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib223","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41418-021-00872-2","article-title":"The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression","volume":"29","author":"Gao","year":"2022","journal-title":"Cell death Differ."},{"issue":"7","key":"10.1016\/j.biopha.2025.118367_bib224","article-title":"Pharmaceutical therapies for necroptosis in myocardial ischemia-reperfusion injury","volume":"10","author":"Zhang","year":"2023","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.biopha.2025.118367_bib225","article-title":"Quercetin attenuates cardiac hypertrophy by inhibiting mitochondrial dysfunction through SIRT3\/PARP-1 pathway","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118367_bib226","article-title":"Resveratrol protects against myocardial ischemic injury in obese mice via activating SIRT3\/FOXO3a signaling pathway and restoring redox homeostasis","volume":"174","author":"Zhu","year":"2024","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib227","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/abbs\/gmab012","article-title":"Resveratrol inhibits necroptosis by mediating the TNF-\u03b1\/RIP1\/RIP3\/MLKL pathway in myocardial hypoxia\/reoxygenation injury","volume":"53","author":"Hu","year":"2021","journal-title":"Acta Biochim. Et. Biophys. Sin."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib228","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/ptr.8177","article-title":"Quercetin inhibits necroptosis in cardiomyocytes after ischemia-reperfusion via DNA-PKcs-SIRT5-orchestrated mitochondrial quality control","volume":"38","author":"Chang","year":"2024","journal-title":"Phytother. Res. PTR"},{"issue":"12","key":"10.1016\/j.biopha.2025.118367_bib229","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/cvr\/cvae144","article-title":"Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia\/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes","volume":"120","author":"Baumgardt","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2025.118367_bib230","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2014.03.005","article-title":"Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion","volume":"72","author":"Aune","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib231","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41401-020-0490-7","article-title":"Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation","volume":"42","author":"Song","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib232","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s10495-013-0866-y","article-title":"The histone deacetylase inhibitor vorinostat prevents TNFalpha-induced necroptosis by regulating multiple signaling pathways","volume":"18","author":"Wang","year":"2013","journal-title":"Apopt. Int. J. Program. Cell Death"},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib233","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1159\/000493672","article-title":"Inhibition of histone deacetylases prevents cardiac remodeling after myocardial infarction by restoring autophagosome processing in cardiac fibroblasts","volume":"49","author":"Wang","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib234","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.113.002416","article-title":"Histone deacetylase inhibition blunts ischemia\/reperfusion injury by inducing cardiomyocyte autophagy","volume":"129","author":"Xie","year":"2014","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib235","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2174\/1566524019666190208102729","article-title":"Histone deacetylase inhibition attenuates cardiomyocyte hypoxia-reoxygenation injury","volume":"18","author":"Williams","year":"2018","journal-title":"Curr. Mol. Med"},{"key":"10.1016\/j.biopha.2025.118367_bib236","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yjmcc.2019.03.008","article-title":"HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia\/reperfusion injury","volume":"130","author":"Yang","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib237","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3892\/ijmm.2017.3101","article-title":"Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway","volume":"40","author":"Guo","year":"2017","journal-title":"Int J. Mol. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib238","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.arcmed.2012.04.007","article-title":"Trichostatin A ameliorates myocardial ischemia\/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis","volume":"43","author":"Yu","year":"2012","journal-title":"Arch. Med Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib239","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/CIRCRESAHA.120.318601","article-title":"Activation of Autophagic Flux Blunts Cardiac Ischemia\/Reperfusion Injury","volume":"129","author":"Xie","year":"2021","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.biopha.2025.118367_bib240","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.bbadis.2016.09.003","article-title":"Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3","volume":"1863","author":"Zhang","year":"2017","journal-title":"Biochim. Et. Biophys. Acta Mol. basis Dis."},{"issue":"7","key":"10.1016\/j.biopha.2025.118367_bib241","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13051","article-title":"Hypertrophic preconditioning attenuates myocardial ischaemia-reperfusion injury by modulating SIRT3-SOD2-mROS-dependent autophagy","volume":"54","author":"Ma","year":"2021","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib242","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/SHK.0000000000002366","article-title":"SIRT3 mediates the cardioprotective effect of therapeutic hypothermia after cardiac arrest and resuscitation by restoring autophagic flux via the PI3K\/AKT\/MTOR PATHWAY","volume":"62","author":"Wang","year":"2024","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib243","article-title":"The study on the role of O-GlcNAcylation of SIRT3 in regulating mitochondrial oxidative stress during simulate myocardial ischemia-reperfusion","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib244","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","article-title":"Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway","volume":"285","author":"Pillai","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118367_bib245","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1434459","article-title":"The role of SIRT3 in homeostasis and cellular health","volume":"18","author":"Trinh","year":"2024","journal-title":"Front. Cell Neurosci."},{"issue":"12","key":"10.1016\/j.biopha.2025.118367_bib246","doi-asserted-by":"crossref","first-page":"22172","DOI":"10.1002\/jcp.28783","article-title":"Mitochonic acid-5 attenuates TNF-\u03b1-mediated neuronal inflammation via activating Parkin-related mitophagy and augmenting the AMPK-Sirt3 pathways","volume":"234","author":"Huang","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib247","doi-asserted-by":"crossref","first-page":"360","DOI":"10.31083\/j.rcm2510360","article-title":"Ferroptosis and its potential determinant role in myocardial susceptibility to ischemia\/reperfusion injury in diabetes","volume":"25","author":"Zhou","year":"2024","journal-title":"Rev. Cardiovasc Med."},{"key":"10.1016\/j.biopha.2025.118367_bib248","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.628988","article-title":"Baicalin prevents myocardial ischemia\/reperfusion injury through inhibiting ACSL4 mediated ferroptosis","volume":"12","author":"Fan","year":"2021","journal-title":"Front Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib249","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.004940","article-title":"Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-Segment-Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling","volume":"9","author":"Bulluck","year":"2016","journal-title":"Circ. Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib250","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41392-025-02216-9","article-title":"STING aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting GPX4 for autophagic degradation","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib251","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","article-title":"Ferroptosis: principles and significance in health and disease","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib252","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s13577-022-00682-9","article-title":"Dexmedetomidine post-conditioning alleviates myocardial ischemia-reperfusion injury in rats by ferroptosis inhibition via SLC7A11\/GPX4 axis activation","volume":"35","author":"Yu","year":"2022","journal-title":"Hum. Cell"},{"key":"10.1016\/j.biopha.2025.118367_bib253","article-title":"Dexmedetomidine inhibits ferroptosis to alleviate hypoxia\/reoxygenation-induced cardiomyocyte injury by regulating the HDAC2\/FPN pathway","author":"Fu","year":"2025","journal-title":"Cardiovasc Drugs Ther."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib254","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14646","article-title":"Attenuation of neuronal ferroptosis in intracerebral hemorrhage by inhibiting HDAC1\/2: microglial heterogenization via the Nrf2\/HO1 pathway","volume":"30","author":"Jiang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"21","key":"10.1016\/j.biopha.2025.118367_bib255","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.1074\/jbc.RA118.007006","article-title":"HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression","volume":"294","author":"Hu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118367_bib256","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1409321","article-title":"Short-chain fatty acids regulate erastin-induced cardiomyocyte ferroptosis and ferroptosis-related genes","volume":"15","author":"He","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118367_bib257","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","author":"Toldo","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118367_bib258","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9743280","article-title":"NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia\/reperfusion injury in diabetic rats","volume":"2017","author":"Qiu","year":"2017","journal-title":"Oxid. Med Cell Longev."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib259","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.biopha.2025.118367_bib260","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9111614","article-title":"An epigenetic insight into NLRP3 inflammasome activation in inflammation-related processes","volume":"9","author":"Raneros","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.118367_bib261","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156108","article-title":"HDAC6 mediates NLRP3 inflammasome activation in the pathogenesis of diabetic retinopathy","volume":"164","author":"Kim","year":"2025","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.biopha.2025.118367_bib262","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnagi.2020.00078","article-title":"Pharmacological inhibition of HDAC6 attenuates NLRP3 inflammatory response and protects dopaminergic neurons in experimental models of Parkinson's disease","volume":"12","author":"Yan","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2025.118367_bib263","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2017.08.029","article-title":"Inhibition of HDAC6 increases acetylation of peroxiredoxin1\/2 and ameliorates 6-OHDA induced dopaminergic injury","volume":"658","author":"Jian","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"28","key":"10.1016\/j.biopha.2025.118367_bib264","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1073\/pnas.0803749105","article-title":"HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation","volume":"105","author":"Parmigiani","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2025.118367_bib265","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9494052","article-title":"Inhibition of HDAC6 activity alleviates myocardial ischemia\/reperfusion injury in diabetic rats: potential role of peroxiredoxin 1 acetylation and redox regulation","volume":"2018","author":"Leng","year":"2018","journal-title":"Oxid. Med Cell Longev."},{"issue":"15","key":"10.1016\/j.biopha.2025.118367_bib266","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1111\/jcmm.16751","article-title":"HDAC6 inhibitor ACY1215 inhibits the activation of NLRP3 inflammasome in acute liver failure by regulating the ATM\/F-actin signalling pathway","volume":"25","author":"Chen","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2025.118367_bib267","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2147\/JIR.S302391","article-title":"Histone deacetylase 6 regulates the activation of M1 macrophages by the glycolytic pathway during acute liver failure","volume":"14","author":"Wang","year":"2021","journal-title":"J. Inflamm. Res"},{"issue":"7775","key":"10.1016\/j.biopha.2025.118367_bib268","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-019-1551-2","article-title":"DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome","volume":"573","author":"Samir","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib269","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.114","article-title":"Histone deacetylase 6 as a novel promising target to treat cardiovascular disease","volume":"3","author":"Wu","year":"2024","journal-title":"Cancer Innov."},{"issue":"7","key":"10.1016\/j.biopha.2025.118367_bib270","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024205","article-title":"Tubastatin A improves post-resuscitation myocardial dysfunction by inhibiting NLRP3-mediated pyroptosis through enhancing transcription factor EB signaling","volume":"11","author":"Xu","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"16","key":"10.1016\/j.biopha.2025.118367_bib271","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165758","article-title":"Epigenetic Mechanisms of Inflammasome Regulation","volume":"21","author":"Poli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib272","first-page":"648","article-title":"The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome","volume":"34","author":"Zhang","year":"2020","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"7","key":"10.1016\/j.biopha.2025.118367_bib273","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107158","article-title":"HDAC3 promotes macrophage pyroptosis via regulating histone deacetylation in acute lung injury","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"issue":"8","key":"10.1016\/j.biopha.2025.118367_bib274","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41419-021-04019-6","article-title":"The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury","volume":"12","author":"Ning","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41419-020-03295-y","article-title":"Roles of HDAC3-orchestrated circadian clock gene oscillations in diabetic rats following myocardial ischaemia\/reperfusion injury","volume":"12","author":"Qiu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.118367_bib276","article-title":"ALDH2 attenuates myocardial pyroptosis through breaking down Mitochondrion-NLRP3 inflammasome pathway in septic shock","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib277","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1248\/bpb.b18-00785","article-title":"Histone deacetylase inhibitor SAHA treatment prevents the development of heart failure after myocardial infarction via an induction of heat-shock proteins in rats","volume":"42","author":"Nagata","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2025.118367_bib278","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2018.04.011","article-title":"HDAC inhibition helps post-MI healing by modulating macrophage polarization","volume":"119","author":"Kimbrough","year":"2018","journal-title":"J. Mol. Cell Cardiol."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib279","doi-asserted-by":"crossref","DOI":"10.1532\/hsf.4919","article-title":"M2 Macrophage-derived exosomes regulate myocardial ischemia-reperfusion and pyroptosis Via ROS\/NLRP3 pathway","volume":"25","author":"Hu","year":"2022","journal-title":"Heart Surg. Forum"},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib280","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.tips.2023.07.004","article-title":"Copper homeostasis and cuproptosis in cardiovascular disease therapeutics","volume":"44","author":"Yang","year":"2023","journal-title":"Trends Pharm. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib281","doi-asserted-by":"crossref","first-page":"595","DOI":"10.23736\/S2724-5683.23.06493-1","article-title":"Bioinformatics analysis of the role of cuproptosis gene in acute myocardial infarction","volume":"72","author":"Fang","year":"2024","journal-title":"Minerva Cardiol. Angiol."},{"key":"10.1016\/j.biopha.2025.118367_bib282","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1016081","article-title":"Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib283","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41435-023-00209-8","article-title":"Potential diagnostic biomarkers: 6 cuproptosis- and ferroptosis-related genes linking immune infiltration in acute myocardial infarction","volume":"24","author":"Miao","year":"2023","journal-title":"Genes Immun."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib284","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/s12967-024-05415-0","article-title":"Leveraging a neutrophil-derived PCD signature to predict and stratify patients with acute myocardial infarction: from AI prediction to biological interpretation","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.biopha.2025.118367_bib285","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41419-022-05460-x","article-title":"FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM","volume":"13","author":"Bi","year":"2022","journal-title":"Cell death Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib286","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41420-024-02054-8","article-title":"Deacetylated MDH1 and IDH1 aggravates PANoptosis in acute liver failure through endoplasmic reticulum stress signaling","volume":"10","author":"Shi","year":"2024","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib287","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2004.10.001","article-title":"Histone deacetylase inhibitors","volume":"40","author":"Monneret","year":"2005","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib288","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/13543776.2013.736493","article-title":"Histone deacetylase inhibitors: a patent review (2009 - 2011)","volume":"23","author":"Carafa","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib289","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4068\/cmj.2016.52.1.1","article-title":"HDAC and HDAC inhibitor: from cancer to cardiovascular diseases","volume":"52","author":"Yoon","year":"2016","journal-title":"Chonnam Med. J."},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib290","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/hr.2016.54","article-title":"Histone deacetyltransferase inhibitors Trichostatin A and Mocetinostat differentially regulate MMP9, IL-18 and RECK expression, and attenuate Angiotensin II-induced cardiac fibroblast migration and proliferation","volume":"39","author":"Somanna","year":"2016","journal-title":"Hypertens. Res. Off. J. Jpn. Soc. Hypertens."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib291","doi-asserted-by":"crossref","first-page":"H2154","DOI":"10.1152\/ajpheart.01015.2009","article-title":"Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition","volume":"298","author":"Zhang","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib292","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cardiores.2007.08.010","article-title":"Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury","volume":"76","author":"Zhao","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib293","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41419-017-0174-5","article-title":"Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation","volume":"9","author":"Milan","year":"2018","journal-title":"Cell death Dis."},{"issue":"427","key":"10.1016\/j.biopha.2025.118367_bib294","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0144","article-title":"Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism","volume":"10","author":"Jeong","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib295","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacbts.2018.05.003","article-title":"Epigenetics in cardiac fibrosis: emphasis on inflammation and fibroblast activation","volume":"3","author":"Felisbino","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.118367_bib296","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/15592294.2015.1024406","article-title":"HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes","volume":"10","author":"Ooi","year":"2015","journal-title":"Epigenetics"},{"issue":"21","key":"10.1016\/j.biopha.2025.118367_bib297","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty Years of HDAC Inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"issue":"6887","key":"10.1016\/j.biopha.2025.118367_bib298","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib299","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/ph3092751","article-title":"Clinical toxicities of histone deacetylase inhibitors","volume":"3","author":"Subramanian","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40360-020-0400-0","article-title":"Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury","volume":"21","author":"Lin","year":"2020","journal-title":"BMC Pharm. Toxicol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib301","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1073\/pnas.1015081108","article-title":"Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy","volume":"108","author":"Cao","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib302","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/med.20178","article-title":"+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets","volume":"30","author":"Schemies","year":"2010","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib303","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tem.2013.12.001","article-title":"SIRT1 and other sirtuins in metabolism","volume":"25","author":"Chang","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib304","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13577-011-0031-2","article-title":"Resveratrol attenuates apoptosis of pulmonary microvascular endothelial cells induced by high shear stress and proinflammatory factors","volume":"24","author":"Xia","year":"2011","journal-title":"Hum. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10863-022-09954-3","article-title":"Resveratrol ameliorates myocardial ischemia\/reperfusion induced necroptosis through inhibition of the Hippo pathway","volume":"55","author":"Tian","year":"2023","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.biopha.2025.118367_bib306","article-title":"Resveratrol attenuate myocardial injury by inhibiting ferroptosis via inducing KAT5\/GPX4 in myocardial infarction","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118367_bib307","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145968","article-title":"Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis","volume":"808","author":"Li","year":"2022","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib308","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1167\/iovs.64.4.31","article-title":"Neuroprotection of SRT2104 in Murine Ischemia\/Reperfusion Injury Through the Enhancement of Sirt1-Mediated Deacetylation","volume":"64","author":"Bai","year":"2023","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2025.118367_bib309","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000042","article-title":"Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokers","volume":"2","author":"Venkatasubramanian","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib310","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/cvr\/cvy062","article-title":"A new strategy to decrease cardiac injury in aged heart following ischaemia-reperfusion: enhancement of the interaction between AMPK and SIRT1","volume":"114","author":"Chen","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib311","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s10020-018-0037-2","article-title":"Myocyte-specific overexpressing HDAC4 promotes myocardial ischemia\/reperfusion injury","volume":"24","author":"Zhang","year":"2018","journal-title":"Mol. Med. (Camb. Mass. )."},{"key":"10.1016\/j.biopha.2025.118367_bib312","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177216","article-title":"Sodium valproate reverses aortic hypercontractility in acute myocardial infarction in rabbits","volume":"988","author":"Guerra-Ojeda","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.118367_bib313","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176475","article-title":"Sodium valproate treatment reverses endothelial dysfunction in aorta from rabbits with acute myocardial infarction","volume":"970","author":"Guerra-Ojeda","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib314","doi-asserted-by":"crossref","first-page":"H968","DOI":"10.1152\/ajpheart.00891.2006","article-title":"Inhibition of histone deacetylase on ventricular remodeling in infarcted rats","volume":"293","author":"Lee","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.118367_bib315","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1405569","article-title":"Targeting histone deacetylase in cardiac diseases","volume":"15","author":"Lu","year":"2024","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib316","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pharmthera.2014.02.012","article-title":"Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases","volume":"143","author":"Eom","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2025.118367_bib317","article-title":"Resveratrol protects against myocardial ischemic injury in obese mice via activating SIRT3\/FOXO3a signaling pathway and restoring redox homeostasis","volume":"174","author":"Zhu","year":"2024","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.biopha.2025.118367_bib318","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCULATIONAHA.123.065005","article-title":"Inhalable stem cell exosomes promote heart repair after myocardial infarction","volume":"150","author":"Li","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118367_bib319","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2023.12.009","article-title":"Stem cell-based therapy in cardiac repair after myocardial infarction: promise, challenges, and future directions","volume":"188","author":"Yan","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib320","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s44161-024-00422-2","article-title":"Markers of imminent myocardial infarction","volume":"3","author":"Gustafsson","year":"2024","journal-title":"Nat. Cardiovasc Res."},{"key":"10.1016\/j.biopha.2025.118367_bib321","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2020.09.007","article-title":"CaMKII exacerbates heart failure progression by activating class I HDACs","volume":"149","author":"Zhang","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"27","key":"10.1016\/j.biopha.2025.118367_bib322","doi-asserted-by":"crossref","first-page":"44281","DOI":"10.18632\/oncotarget.17471","article-title":"The optimization of cell therapy by combinational application with apicidin-treated mesenchymal stem cells after myocardial infarction","volume":"8","author":"Cho","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib323","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40360-019-0294-x","article-title":"Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure","volume":"20","author":"Freundt","year":"2019","journal-title":"BMC Pharm. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib324","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00395-018-0710-1","article-title":"Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy","volume":"114","author":"Moore","year":"2018","journal-title":"Basic Res. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118367_bib325","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/15592294.2018.1460032","article-title":"Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities","volume":"13","author":"Lkhagva","year":"2018","journal-title":"Epigenetics"},{"key":"10.1016\/j.biopha.2025.118367_bib326","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.yjmcc.2017.12.004","article-title":"HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury","volume":"114","author":"Herr","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2025.118367_bib327","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-7-10","article-title":"HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation","volume":"7","author":"Nural-Guvener","year":"2014","journal-title":"Fibrogenes. Tissue Repair"},{"key":"10.1016\/j.biopha.2025.118367_bib328","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vph.2015.02.004","article-title":"NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis","volume":"70","author":"Cattelan","year":"2015","journal-title":"Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib329","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086977","article-title":"Sirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in mice","volume":"9","author":"Shalwala","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib330","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1038\/s41598-020-61886-3","article-title":"Rhein, a novel Histone Deacetylase (HDAC) inhibitor with antifibrotic potency in human myocardial fibrosis","volume":"10","author":"Barbosa","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib331","doi-asserted-by":"crossref","first-page":"H332","DOI":"10.1152\/ajpheart.00444.2019","article-title":"LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p\/HDAC3 axis","volume":"318","author":"Su","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib332","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10557-021-07159-1","article-title":"The protective role of Bmal1-regulated autophagy mediated by HDAC3\/SIRT1 pathway in myocardial ischemia\/reperfusion injury of diabetic rats","volume":"36","author":"Qiu","year":"2022","journal-title":"Cardiovasc Drugs Ther."},{"issue":"10","key":"10.1016\/j.biopha.2025.118367_bib333","first-page":"3549","article-title":"Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice","volume":"22","author":"Granger","year":"2008","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118367_bib334","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1152\/japplphysiol.00617.2019","article-title":"Scriptaid\/exercise-induced lysine acetylation is another type of posttranslational modification occurring in titin","volume":"128","author":"Huang","year":"2020","journal-title":"J. Appl. Physiol. (Bethesda Md. 1985)."},{"issue":"7","key":"10.1016\/j.biopha.2025.118367_bib335","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/dom.12896","article-title":"Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice","volume":"19","author":"Gaur","year":"2017","journal-title":"Diabetes Obes. Metab."},{"issue":"22","key":"10.1016\/j.biopha.2025.118367_bib336","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","article-title":"Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy","volume":"113","author":"Kong","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.biopha.2025.118367_bib337","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065474","article-title":"HDAC inhibition elicits myocardial protective effect through modulation of MKK3\/Akt-1","volume":"8","author":"Zhao","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118367_bib338","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/jpet.111.189910","article-title":"Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis","volume":"341","author":"Zhang","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2025.118367_bib339","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022550","article-title":"Improvement of cardiac function in mouse myocardial infarction after transplantation of epigenetically-modified bone marrow progenitor cells","volume":"6","author":"Rajasingh","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2025.118367_bib340","doi-asserted-by":"crossref","DOI":"10.1177\/10742484221140303","article-title":"Association of valproic acid use with post-myocardial infarction heart failure development: a meta-analysis of two retrospective case-control studies","volume":"27","author":"English","year":"2022","journal-title":"J. Cardiovasc. Pharmacol. Ther."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500561X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500561X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:26:32Z","timestamp":1772760392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500561X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":340,"alternative-id":["S075333222500561X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118367","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylases in myocardial infarction: Orchestrating programmed cell death pathways and emerging therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118367"}}